deBlacam C, Byrne C, Hughes E, McIlroy M, Bane F, Hill ADK, Young LS. HOXC11–SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib. British Journal of Cancer. 2011 Jun 07;105(1):118–23. doi: 10.1038/bjc.2011.193.